logo
Share SHARE
FONT-SIZE Plus   Neg

Carlsberg To Delist Baltika Irrespective Of Voluntary Offer - Quick Facts

Carlsberg A/S (CARL-B.CO, CABGY.PK) Tuesday updated on its plans to buyout Russia-based Baltika Brewery (PKBA.ME) and said Baltika's supervisory board would decide on delisting Baltika from the Russian stock exchange. Further, the delisting was not connected to the buyout, Carlsberg added.

In its announcement of February 20, 2012, Carlsberg revealed its intentions to make a voluntary offer for the remaining shares of Baltika by May 2012. Currently, Carlsberg's holding in Baltika is about 85 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Coca-Cola Company (KO) reported a profit for the first-quarter of 2017 that declined 20 percent from the prior year. Net revenues declined 11%, reflecting unfavorable impacts from structural changes of 10% and foreign currency of 1%. The company remains on track to deliver its underlying revenue and profit targets for the full year. Eli Lilly and Co. (LLY) reported a loss for the first quarter of 2017 compared to profit in the prior year, primarily hurt by lower operating income, partially offset by higher other income. But, quarterly revenue increased 7 percent, driven by 9 percent pharmaceutical volume growth from Trulicity, Taltz and other new products. Capricor Therapeutics, Inc., a clinical-stage biotechnology company for cardiac and other medical conditions, announced Tuesday positive six-month results from the randomized phase I/II HOPE clinical trial in Duchenne muscular dystrophy or DMD. The HOPE clinical trial was designed to evaluate the safety and exploratory efficacy of CAP-1002.
comments powered by Disqus
Follow RTT